Related Experiment Video

Updated: Mar 15, 2026

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
08:01

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

2.3K

[Malignant Pleural Mesotheliomas]

C Biancosino1, B Redwan1, M Krüger2

  • 1Klinik für Thoraxchirurgie, Helios Universitätsklinikum Wuppertal, Universität Witten-Herdecke, Wuppertal, Deutschland.

Zentralblatt Fur Chirurgie
|September 10, 2016
PubMed

Insights

Malignant pleural mesothelioma (MPM) is an aggressive asbestos-linked cancer. Diagnosis requires tissue samples, and multi-modal treatment is superior, with a shift towards radical pleurectomy (RP) over extrapleural pneumonectomy (EPP).

Area of Science:

  • Oncology
  • Thoracic Surgery
  • Pathology

Background:

  • Malignant pleural mesothelioma (MPM) is an aggressive cancer originating from pleural mesothelial cells.
  • Asbestos exposure is the primary risk factor, with a long latency period of 30-60 years.
  • Clinical presentation is often nonspecific, necessitating accurate pathological diagnosis.

Purpose of the Study:

  • To summarize the current understanding of malignant pleural mesothelioma (MPM).
  • To highlight diagnostic methods and histological classifications.
  • To discuss treatment approaches, emphasizing the shift in surgical philosophies.

Main Methods:

  • Diagnosis relies on adequate tissue specimens, with video-assisted thoracoscopic surgery (VATS) offering the highest diagnostic yield.
  • Histological classification includes epithelioid, sarcomatoid, and biphasic subtypes.
  • Staging involves invasive tests to guide interdisciplinary treatment planning.

Main Results:

  • Multi-modal treatment (surgery, radiation oncology, chemotherapy) is superior for eligible patients.
  • The primary goal of surgical therapy is macroscopic complete resection.
  • A paradigm shift has occurred from extrapleural pneumonectomy (EPP) to radical pleurectomy (RP) as the preferred surgical option.

Conclusions:

  • Accurate diagnosis and staging are crucial for optimal multi-modal treatment of MPM.
  • Radical pleurectomy (RP) is increasingly favored over extrapleural pneumonectomy (EPP) in surgical management.
  • Understanding MPM subtypes and treatment options is vital for patient outcomes.

More Related Videos

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice07:54

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Published on: December 21, 2019

7.4K
Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model09:31

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model

Published on: October 2, 2015

9.8K

Related Concept Videos

Pleural Disorders: Types and Brief Description01:30

Pleural Disorders: Types and Brief Description

The pleura is a vital part of the respiratory system. It's a double-layered membrane surrounding the lungs and lining the chest cavity. The two layers of the pleura are:
861
Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
973
Pleura of the Lungs01:13

Pleura of the Lungs

The lungs are nestled in a cavity, shielded by the pleura. The pleura, a form of serous membrane, wraps around each lung. This membrane arrangement consists of two layers: the visceral and parietal pleurae. The visceral pleura lines the surface of the lungIn contrast, the parietal pleura is the outer layer and contacts to the thoracic wall, the mediastinum, and the diaphragm. The hilum is the point of connection between the visceral and parietal layers. The space between the parietal and...
9.1K
Pleural Effusion I: Introduction01:25

Pleural Effusion I: Introduction

Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
5.2K
Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
1.3K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
6.0K